Allergy/Imm Medical News about Follicular lymphoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies
Immunotherapy, 11/05/09

Seiler T et al. – High response rates and durable remissions have been seen with both 90Y–ibritumomab tiuxetan and 131I–tositumomab. However, refractoriness to immunochemotherapy still remains a problem, especially in relapsed disease. Several novel targeted agents show encouraging activity in follicular lymphoma. This review will focus on current treatment strategies in this disease.

<< Previous
Diagnosis and treatment of immunologically infertile women with...

Next >>
Implementing the number needed to harm in clinical practice: risk...

Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkins lymphoma: The Iowa Womens Health Study
International Journal of Cancer, 11/05/09 Relevance Score: 68%

Follicular lymphomas with plasmacytic differentiation include two subtypes
Modern Pathology, 10/22/09 Relevance Score: 68%

Follicular lymphoma cells induce T-cell immunological synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy
Blood, 10/02/09 Relevance Score: 68%

Utility of the follicular lymphoma international prognostic index and the international prognostic index in assessing prognosis and predicting first-line treatment efficacy in follicular lymphoma patients
Acta Haematologica, 11/05/09 Relevance Score: 67%